Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered question first ministerially corrected answering member label attachment file name title previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

754729

	registered interest
	date	20/07/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Pharmacy
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what the total number of repeat prescriptions issued by (a) high street and (b) internet pharmacies has been in each year since 2007 in (i) England and (ii) each local authority area.
	tabling member constituency	Leicester South
	tabling member printed	Jonathan Ashworth
	uin	6406
	answer	answer is ministerial correction date of answer 11/09/2017 answer text <p>The total number of repeat dispensing prescription items issued by wholly distance selling pharmacies, including internet pharmacies, and other community pharmacies, including those on the high street, for each year since April 2013 in England is detailed in the table below:</p><table><tbody><tr><td><p>Time Period</p></td><td><p>Repeat Dispensing Prescription Items for Distant Selling Pharmacies</p></td><td><p>Repeat Dispensing Prescription Items for Other Community Pharmacies</p></td><td><p>Yearly Total</p></td></tr><tr><td><p>2013 (Apr-Dec 2013)</p></td><td><p>625,157</p></td><td><p>49,222,450</p></td><td><p>49,847,607</p></td></tr><tr><td><p>2014 (Jan-Dec 2014)</p></td><td><p>1,076,060</p></td><td><p>73,769,909</p></td><td><p>74,845,969</p></td></tr><tr><td><p>2015 (Jan-Dec 2015)</p></td><td><p>1,482,942</p></td><td><p>84,411,853</p></td><td><p>85,894,795</p></td></tr><tr><td><p>2016 (Jan-Dec 2016)</p></td><td><p>2,001,326</p></td><td><p>95,730,820</p></td><td><p>97,732,146</p></td></tr><tr><td><p>2017 (Jan-May 2017)</p></td><td><p>930,753</p></td><td><p>42,216,958</p></td><td><p>43,147,711</p></td></tr><tr><td><p>Total</p></td><td><p>6,116,238</p></td><td><p>345,351,990</p></td><td><p>351,468,228</p></td></tr></tbody></table><p>The requested data is not provided before 2013 as the NHS Business Services Authority only holds prescription payment data for a period of 60 months, at which point it is destroyed in line with their records management policy. Also this coincides with NHS England becoming responsible for commissioning community pharmacy services from April 2013. As such, data is attached on repeat dispensing prescription items by NHS England local areas, rather than local authority areas.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 11/09/2017 14:29:46 question first ministerially corrected 12/09/2017 09:25:45 answering member 4067 label Biography information for Steve Brine attachment 1 file name PQ6406 Repeats appendix FINAL.xlsx title Repeat prescriptions by NHS England area previous answer version 9595 answering member constituency Winchester answering member printed Steve Brine answering member 4067 label Biography information for Steve Brine
	tabling member	4244 label Biography information for Jonathan Ashworth

757686

	registered interest
	date	05/09/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Measles: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what the immunisation rate is for measles; and what steps the Government is taking to improve measles immunisation coverage.
	tabling member constituency	Warley
	tabling member printed	John Spellar
	uin	8870
	answer	answer is ministerial correction date of answer 13/09/2017 answer text <p>Protection against measles is provided in the combination measles, mumps and rubella vaccine (MMR).</p><p>The latest <del class="ministerial">England</del> vaccine coverage figures <ins class="ministerial">for the United Kingdom</ins> (January to March 2017) show that uptake of one dose of MMR vaccine at two years was 91.7% and at five years was 95.4%, exceeding the World Health Organisation’s elimination target. Uptake of two MMR doses at five years was 88.1%.</p><p> </p><p>In November 2016, a measles and rubella elimination strategy group was established to oversee the development of a United Kingdom-wide Measles and Rubella elimination strategy. This strategy will focus on sustaining very high coverage of MMR in children below five years of age and on providing opportunities for MMR catch-up to older population groups at risk for measles and/or rubella. Public Health England (PHE) continues to work with others to supply information for health professionals and the public on the benefits and risks associated with MMR.</p><p> </p><p>PHE and NHS England work closely with providers at a local level to target specific communities where uptake of the MMR vaccine is known to be poor.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 13/09/2017 15:11:29 question first ministerially corrected 15/09/2017 14:52:33 answering member 4067 label Biography information for Steve Brine previous answer version 11365 answering member constituency Winchester answering member printed Steve Brine answering member 4067 label Biography information for Steve Brine
	tabling member	318 label Biography information for John Spellar

777814

	registered interest
	date	25/10/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Prescription Drugs: Prices
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, which prescription drugs had the highest increase in price to the NHS in the last 10 years for which data is available.
	tabling member constituency	Vale of Clwyd
	tabling member printed	Chris Ruane
	uin	109619
	answer	answer is ministerial correction date of answer 03/11/2017 answer text <p>The table below shows the top five individual medicines <del class="ministerial">and chemicals</del> that have shown the highest increase in <ins class="ministerial">cost</ins> <del class="ministerial">price </del> over the last 10 years for Net Ingredient Cost (NIC) per prescription item <del class="ministerial">and NIC per quantity</del>. Prescription medicines<del class="ministerial">/chemicals</del> have only been included where there was prescribing in both 2006 and 2016.</p><p><ins class="ministerial">For any medicine listed, it does not necessarily mean that the price has increased. For example, the cost per prescription item will be higher if the quantity being prescribed per prescription item has increased.</ins></p><p>This is based on Prescription Cost Analysis (PCA) data. PCA data is based on analysis of all prescriptions dispensed in the community i.e. by community pharmacists and appliance contractors, dispensing doctors, and prescriptions submitted by prescribing doctors for items personally administered in England. PCA data do not cover drugs dispensed in hospitals, including mental health trusts, or private prescriptions.</p><p> </p><p>Costs vary over time due to numerous factors including medicines going off patent and becoming available generically, unlicensed medicines becoming licensed medicines, shortages, the level of competition for generic medicines, as well as centrally agreed pricing schemes such as the Pharmaceutical Price Regulation Scheme.</p><p> </p><p>The Department is working closely with the Competition and Markets Authority on a number of investigations into unwarranted price rises of unbranded generic medicines. Where companies have breached competition law, we will seek damages and invest that money back into the National Health Service.</p><p> </p><table><tbody><tr><td colspan="4"><p>The top five medicines with the highest increase in Net Ingredient<sup>1</sup> Cost per prescription item<sup>2</sup></p></td></tr><tr><td><p>Drug Name</p></td><td><p>2006</p></td><td><p>2016</p></td><td><p>Increase</p></td></tr><tr><td><p>Orfadin_Cap 10mg</p></td><td><p>£5,436.74</p></td><td><p>£20,030.86</p></td><td><p>£14,594.12</p></td></tr><tr><td><p>Cerezyme_I/V Inf 400u Vl (Dry)</p></td><td><p>£18,143.17</p></td><td><p>£30,397.85</p></td><td><p>£12,254.68</p></td></tr><tr><td><p>Chenodeoxycholic Acid_Cap 250mg</p></td><td><p>£88.57</p></td><td><p>£9,580.10</p></td><td><p>£9,491.54</p></td></tr><tr><td><p>Trientine Dihydroch_Cap 300mg (Old)</p></td><td><p>£218.58</p></td><td><p>£5,488.22</p></td><td><p>£5,269.64</p></td></tr><tr><td><p>Sod Benz_Liq Spec 400mg/5ml</p></td><td><p>£361.95</p></td><td><p>£4,352.92</p></td><td><p>£3,990.96</p></td></tr></tbody></table><p>Source: Prescription Cost Analysis</p><p> </p><p>Notes:</p><p> </p><p><sup>1</sup>NIC is the basic cost of a drug. It does not take account of discounts, dispensing costs, fees or prescription charges income, so the amount the NHS spent will be slightly different.</p><p> </p><p><sup>2</sup>Prescriptions are written on a prescription form known as an FP10. Each single item written on the form is counted as a prescription item.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 03/11/2017 14:32:18 question first ministerially corrected 12/12/2017 13:55:12 answering member 4067 label Biography information for Steve Brine previous answer version 20077 answering member constituency Winchester answering member printed Steve Brine answering member 4067 label Biography information for Steve Brine
	tabling member	534 label Biography information for Chris Ruane

778216

	registered interest
	date	26/10/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Tobacco: Packaging
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what recent assessment he has made of the effect of the introduction of plain cigarette packaging on smoking rates.
	tabling member constituency	Brentwood and Ongar
	tabling member printed	Alex Burghart
	uin	110024
	answer	answer is ministerial correction date of answer 03/11/2017 answer text <p>The Standardised Packaging of Tobacco Products Regulations 2015 came into force on 20 May 2016. The Government consulted on the introduction of standardised packaging and published an impact assessment, which included benefits to public health. The Government will review these regulations by <ins class="ministerial">2021</ins> <del class="ministerial">2020</del>.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 03/11/2017 11:41:50 question first ministerially corrected 21/03/2018 13:09:21 answering member 4067 label Biography information for Steve Brine previous answer version 19960 answering member constituency Winchester answering member printed Steve Brine answering member 4067 label Biography information for Steve Brine
	tabling member	4613 label Biography information for Alex Burghart

782158

	registered interest
	date	01/11/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Action On Smoking and Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, pursuant to the Answer of 4 September 2017 to Question 6854, whether his Department has provided funding from non-section 64 sources to the organisation Action on Smoking and Health in the 2017-18 financial year or any of the last 10 financial years.
	tabling member constituency	Kettering
	tabling member printed	Mr Philip Hollobone
	uin	110843
	answer	answer is ministerial correction date of answer 06/11/2017 answer text <p>In the past 10 years, the Department has paid Action on Smoking and Health (ASH) a total of £16,016.40 in non-grant funding for help in implementing additional strategies targeted at tackling health inequalities.</p><p> </p><p>Grant funding has also been given to ASH as <ins class="ministerial">in the attached table </ins><del class="ministerial">follows</del>. <ins class="ministerial">Any payment to ASH in respect of activity for 2017-18 will depend upon the outcome of a competitive process to secure support for delivery of the Tobacco Control Plan. </ins>The Department’s financial records do not provide the level of detail to confirm whether funding was made under the legal power Section 64 of the Health and Public Services Act 1968 for all of this period. However, local records can confirm <ins class="ministerial">only</ins> Section 64 has been used since the financial year 2012/13.</p><p> </p><p> </p> answering member constituency Winchester answering member printed Steve Brine question first answered 06/11/2017 17:30:52 question first ministerially corrected 08/11/2017 10:47:05 answering member 4067 label Biography information for Steve Brine attachment 1 file name Grant Funding to Action on Smoking and Health.docx title Grant Funding to ASH previous answer version 20537 answering member constituency Winchester answering member printed Steve Brine answering member 4067 label Biography information for Steve Brine
	tabling member	1537 label Biography information for Mr Philip Hollobone

797514

	registered interest
	date	29/11/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Thyroid Gland: Diseases
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what medicines NHS England has approved for patients with thyroid conditions
	tabling member constituency	Southampton, Itchen
	tabling member printed	Royston Smith
	uin	116477
	answer	answer is ministerial correction date of answer 07/12/2017 answer text <p><del class="ministerial">For unbranded generics the Government relies on completion to keep prices down which generally works well and has led to low prices of these medicines. We alert the Competition and Markets Authority (CMA) when we believe that competition does not work. In the case of liothyronine, the CMA is currently investigating Concordia’s potential abuse of its dominant position to overcharge the National Health Service for liothyronine.</del></p><p> </p><p><del class="ministerial">In primary care community pharmacies are incentivised to source products at the lowest possible cost by allowing them to retain the medicines margin (the difference between what the NHS reimburses a pharmacy for a product and how much the pharmacy purchases it for) up to £800 million in England. In secondary care, competitive tenders ensure value-for-money to the NHS.</del></p><p><ins class="ministerial"> <p><ins class="ministerial">NHS England is not responsible for approving medicines. The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for ensuring that medicines and medical devices work and are acceptably safe. The National Institute for Health and Care Excellence makes recommendations for the National Health Service on whether medicines and other treatments represent a clinically and cost effective use of NHS resources.</ins></p><p><ins class="ministerial"><strong> </strong></ins></p><p><ins class="ministerial">A list of medicines licensed by the MHRA for the treatment of thyroid conditions is attached. The list is split into two sections because thyroid conditions can be split into either those associated with an overactive thyroid (hyperthyroidism), or an underactive thyroid (hypothyroidism). The list contains only those medicines licensed for overactive and underactive thyroid. It should be noted that not all of the medicines listed will be available on the market at any one time. </ins></p></ins></p> answering member constituency Winchester answering member printed Steve Brine question first answered 07/12/2017 15:27:25 question first ministerially corrected 07/12/2017 18:20:31 answering member 4067 label Biography information for Steve Brine attachment 1 file name 2017 12 06 Thyroid medicines formatted.xls title List of thyroid medicines previous answer version 27995 answering member constituency Winchester answering member printed Steve Brine answering member 4067 label Biography information for Steve Brine
	tabling member	4478 label Biography information for Royston Smith

222966

	registered interest
	date	23/02/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Mental Health Services: Children
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, when he expects that the Child and Adolescent Mental Health Services Dataset will start publishing data; and if he will make a statement.
	tabling member constituency	Liverpool, Wavertree
	tabling member printed	Luciana Berger
	uin	225018
	answer	answer is ministerial correction date of answer 26/02/2015 answer text <p><ins class="ministerial">The Health and Social Care Information Centre advise that the collection of data for the Child and Adolescent Mental Health Services dataset will start at the beginning of February 2016. The first submission period will cover January to March 2016. Statistical reports based on the initial data collection will be published in mid-2016.</ins></p><p> </p><p> </p><p> </p><p><del class="ministerial">The National Institute for Health and Care Excellence guidance <em>Multiple sclerosis: management of multiple sclerosis in primary and secondary care</em>, updated in October 2014, sets out best practice on the diagnosis, treatment, care and support of people with multiple sclerosis (MS). The guidance makes a range of recommendations on drug based treatments for MS, but also highlights the importance of involving professionals who can meet the needs of the patient in the best way, such as physiotherapists and occupational therapists. </del></p><p> </p><p> </p><p><ins class="ministerial"></ins></p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p><del class="ministerial">With regard to early diagnosis, MS is a difficult condition to diagnose as a number of the symptoms such as fatigue, depression or dizziness may be unrelated. The guidance sets out a number of initial presentations that clinicians should be aware of when looking for signs of MS. It also recommends a number of assessments a clinician should make, including testing of vision and blood tests before referral to a consultant neurologist, who can confirm or exclude a diagnosis of MS, subject to investigation.</del></p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb question first answered 26/02/2015 15:20:43 question first ministerially corrected 27/02/2015 13:56:12 answering member 1439 label Biography information for Norman Lamb previous answer version 46777 answering member constituency North Norfolk answering member printed Norman Lamb answering member 1439 label Biography information for Norman Lamb
	tabling member	4036 label Biography information for Luciana Berger

669014

	registered interest
	date	06/01/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Mental Health Services: Children
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how much the NHS has spent on child mental health services in England and Wales in each year since 2010.
	tabling member constituency	Westmorland and Lonsdale
	tabling member printed	Tim Farron
	uin	58724
	answer	answer is ministerial correction date of answer 11/01/2017 answer text <p>The available estimated National Health Service spend on children and young people’s mental health services in England only from 2010 is provided below. Healthcare is a devolved responsibility and the Department is not able to give information on the amount spent by the Welsh Government.</p><p> </p><p>NHS Programme Budgeting data included estimated spending on children and young people’s mental health between 2009/10 and 2012/13 are found on NHS England’s website here:</p><p><a href="https://www.networks.nhs.uk/nhs-networks/health-investment-network/news/2012-13-programme-budgeting-data-is-now-available" target="_blank">https://www.networks.nhs.uk/nhs-networks/health-investment-network/news/2012-13-programme-budgeting-data-is-now-available</a></p><p>NHS England’s financial reporting system estimated spending on children and young people’s mental health services in 2015/16 is set out in the following table.</p><p> </p><table><tbody><tr><td><p>Clinical Commissioning Group Spend</p></td><td><p>2015 to 2016 Outturn <ins class="ministerial">(thousands)</ins> <del class="ministerial">(millions)</del></p></td></tr><tr><td><p>Children and young people’s mental health (excluding learning disability)</p></td><td><p>476,875</p></td></tr><tr><td><p>Children and young people’s eating disorders</p></td><td><p>39,518</p></td></tr><tr><td><p>Total Clinical Commissioning Group Children and Young People’s Mental Health (excluding learning disability)</p></td><td><p>516,393</p></td></tr><tr><td><p> </p></td><td><p> </p></td></tr><tr><td><p>Specialised Commissioning Spend</p></td><td><p>2015 to 2016 Outturn <ins class="ministerial">(thousands)</ins> <del class="ministerial">(millions)</del></p></td></tr><tr><td><p>Tier 4</p></td><td><p>295,301</p></td></tr><tr><td><p>Total Specialised Commissioning Children and Young People’s Mental Health</p></td><td><p>295,301</p></td></tr></tbody></table><p>* Children and young people’s mental health spend data is not available from NHS England’s formal financial planning and reporting before 2015/16.</p><p> </p><p>NHS England published the Clinical Commissioning Guidance Improvement and Assessment Framework for Mental Health on 27 October 2016. It includes a specific indicator on children and young people’s mental health that takes in planning, quality assurance and finance and is weighted towards those meeting the mental health investment standard for children and young people.</p> answering member constituency Oxford West and Abingdon answering member printed Nicola Blackwood question first answered 11/01/2017 17:56:19 question first ministerially corrected 12/01/2017 14:31:15 answering member 4019 label Biography information for Baroness Blackwood of North Oxford previous answer version 29419 answering member constituency Oxford West and Abingdon answering member printed Nicola Blackwood answering member 4019 label Biography information for Baroness Blackwood of North Oxford
	tabling member	1591 label Biography information for Tim Farron

579500

	registered interest
	date	09/09/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Junior Doctors: Pay
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, if he will make a comparative assessment of the level of proposed weekend pay under the new junior doctors' contract with weekend pay for (a) prison officers, (b) fire fighters, (c) police officers, (d) call centre workers, (e) consultants and (f) nurses, midwives and physios.
	tabling member constituency	Torbay
	tabling member printed	Kevin Foster
	uin	45817
	answer	answer is ministerial correction date of answer 19/09/2016 answer text <p>Junior doctors already work weekends, and they will continue to be fairly rewarded for work undertaken at the weekend using the weekend allowance proposed by the British Medical Association negotiators. Comparative rates are set out in the <ins class="ministerial">attached</ins> table<del class="ministerial"> below</del>.</p><p> </p><p>Because of the allowance based approach to weekend working, the effective hourly rate juniors are paid will vary depending on how many hours they work over how many weekends. In almost all cases junior doctors will receive weekend pay better than other National Health Service professional staff.</p><p> </p><p>A typical rota for a junior doctor involves an average of 6.5 hours a week being worked at weekends. (i.e. they work two long shifts of 13 hours every four weekends). This is split evenly over Saturdays and Sundays and includes night work.</p><p> </p><p>For working those weekend hours the percentage hourly supplement across all the hours worked for different groups of NHS staff would be</p><p>- 66% for a junior doctor (37% for night work plus an additional 7.5% weekend allowance set as a percentage of basic pay)</p><p>- 56% for a band 3 Health Care Assistant (37% for Saturday, 74% for Sunday)</p><p>- 45% for a nurse (30% for Saturday, 60% for Sunday)</p><p>- 33% for a consultant</p><p> </p><p><strong><br /> </strong></p><p> </p><p> </p><table><tbody><tr><td><p><del class="ministerial"> </del></p></td><td><p><del class="ministerial">Payment</del></p></td></tr><tr><td><p><del class="ministerial">Junior doctors</del></p></td><td><p><del class="ministerial">Weekend night shifts ending by 10am. Time plus 37%. Weekend allowance - + 10% 1in2 - + 7.5% - + 6% - + 4% - + 3% - No allowance</del></p></td></tr><tr><td><p><del class="ministerial">Consultants</del></p></td><td><p><del class="ministerial">4hour Programmed Activity is reduced to 3 hours, effectively Time + 33%</del></p></td></tr><tr><td><p><del class="ministerial">Nurses</del></p></td><td><p><del class="ministerial">Time + 30% Saturday time +60% Sunday</del></p></td></tr><tr><td><p><del class="ministerial">Prison officers *</del></p></td><td><p><del class="ministerial">Time + 17%</del></p></td></tr><tr><td><p><del class="ministerial"> </del></p></td><td><p><del class="ministerial"> </del></p></td></tr><tr><td><p><del class="ministerial">Firefighters *</del></p></td><td><p><del class="ministerial">Shift duty covers shifts 24 hours, 7 days. No premia</del></p></td></tr><tr><td><p><del class="ministerial">Police Officers *</del></p></td><td><p><del class="ministerial">Time plus 10% for nights only (8pm-6am)</del></p></td></tr><tr><td><p><del class="ministerial">Call centre workers *</del></p></td><td><p><del class="ministerial">Between Time + 5% and Time + 40%</del></p></td></tr></tbody></table><p> </p><p><del class="ministerial">*Income Data Services study</del></p> answering member constituency Ludlow answering member printed Mr Philip Dunne question first answered 19/09/2016 17:00:01 question first ministerially corrected 20/09/2016 09:51:13 answering member 1542 label Biography information for Philip Dunne attachment 1 file name Comparative weekend pay rates PQ45817.docx title Comparative Pay Rates PQ45817 previous answer version 12257 answering member constituency Ludlow answering member printed Mr Philip Dunne answering member 1542 label Biography information for Philip Dunne
	tabling member	4451 label Biography information for Kevin Foster

599539

	registered interest
	date	11/10/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Circle
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what assessment his Department has made of the potential effect of decisions taken by Circle Holdings PLC in the delivery of musculoskeletal services in Greenwich on the financial capacity of the local healthcare trust to sustain accident and emergency services at University Hospital Lewisham and Queen Elizabeth Hospital Woolwich; and if he will make a statement.
	tabling member constituency	Eltham
	tabling member printed	Clive Efford
	uin	48002
	answer	answer is ministerial correction date of answer 17/10/2016 answer text <p>The procurement of local health services by means of competitive tendering is a matter for the local National Health Service.</p><p> </p><p>We are advised by NHS England that Greenwich Clinical Commissioning Group’s Turnaround Director and Musculoskeletal (MSK) Programme Manager met the senior management team of Lewisham and Greenwich Healthcare Trust in March 2016. We understand that the implications of the MSK service procurement were discussed in detail, and that there were no concerns with regard to the viability of any other services the Trust provides.</p><p> </p><p>We are further advised by NHS England that it undertook an assurance of the procurement process for the MSK service in Greenwich in August 2016<ins class="ministerial">. We also understand that NHS Improvement was aware of the procurement and briefly discussed it with the Trust during a standing monthly meeting on 21 June 2016. </ins> <del class="ministerial">and as part of this also met with the Trust to discuss the implications of the procurement for the trust.</del></p><p>We understand that Circle Health has been engaging with Lewisham and Greenwich Healthcare Trust as part of the mobilisation process, including developing clinical and operational delivery plans to provide integrated services.</p> answering member constituency Ludlow answering member printed Mr Philip Dunne question first answered 17/10/2016 16:19:10 question first ministerially corrected 17/11/2016 14:14:49 answering member 1542 label Biography information for Philip Dunne previous answer version 14633 answering member constituency Ludlow answering member printed Mr Philip Dunne answering member 1542 label Biography information for Philip Dunne
	tabling member	165 label Biography information for Clive Efford